Long-term PPI use does not increase hip fracture risk in Alzheimer’s patients
Researchers have found that the long-term proton pump inhibitor use does not increase the risk of hip fracture among persons with Alzheimer's disease...
List view / Grid view
Researchers have found that the long-term proton pump inhibitor use does not increase the risk of hip fracture among persons with Alzheimer's disease...
Scientists in Germany have developed a test using electric fields and Raman spectroscopy to ascertain specific antibiotic resistance of pathogens and thus enable the prescription of effective treatment.
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days...
Researchers have developed a fluorescing nanoparticle capable of finding tumours, lighting up upon arrival and being activated with light to generate heat to destroy the cancer cells...
Human tissue samples linked by microfluidic channels replicate interactions of multiple organs.
Researchers at the Moffitt Cancer Center in Florida have combined single-cell imaging of cancer cells in mice with mathematical modelling to establish which drug characteristics determine its efficacy.
A study in Canada has demonstrated that generic antiplatelet drugs appear to be as equally effective as a brand name drug for heart patients.
A landmark £40million has been awarded to the UK Dementia Research Institute, via the Medical Research Council, for a new iconic hub building at University College London...
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
The FDA has approved tests intended to be used as donor screening tests on samples from individual human donors, including volunteer donors of whole blood and blood components...
Researchers have found that incorporating imaging technologies more precisely can predict heart attack risk...
An immunotherapy drug embedded in a slow-release hydrogel appears to be highly effective at killing cancer cells...
A new technology could allow researchers to fit more biochemical probes onto a single biochip and reduce the cost of screening and analyzing changes associated with disease development...
The FDA has approved Trogarzo for adult patients whose HIV infections cannot be successfully treated...
Scientists reveal that this dangerous drug could suppress nerve cell death...